Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
about
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interactionThe dual role of complement in cancer and its implication in anti-tumor therapyThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsAdvances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ TransplantationInnate and adaptive immune cells in the tumor microenvironmentDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsHarnessing immunosurveillance: current developments and future directions in cancer immunotherapyAntigen-specific immunotherapy of cervical and ovarian cancerPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsTargeted immune therapy of ovarian cancerStroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesisState-of-the-art of regulatory dendritic cells in cancerThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Activation of tonsil dendritic cells with immuno-adjuvants.Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factorsStreptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking.Lymphocytes in cancer development: polarization towards pro-tumor immunityCD8+ Tregs in lupus, autoimmunity, and beyond.The role of chemoattractant receptors in shaping the tumor microenvironment.Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsEctonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-γ-mediated suppressor activities.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.Tregs and rethinking cancer immunotherapy.How tolerogenic dendritic cells induce regulatory T cellsIdentification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral bloodThe indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.Mechanisms of malignant glioma immune resistance and sources of immunosuppressionIndoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.Tc17 cells in patients with uterine cervical cancerImmunity and immune suppression in human ovarian cancer.Signatures of human regulatory T cells: an encounter with old friends and new playersPlasmacytoid dendritic cells lead the charge against tumors.Consensus nomenclature for CD8(+) T cell phenotypes in cancerExpression of Leukocyte Inhibitory Immunoglobulin-like Transcript 3 Receptors by Ovarian Tumors in Laying Hen Model of Spontaneous Ovarian Cancer.Role of chemokines in tumor growth.Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.
P2860
Q24309134-11517DE8-CCCC-41D1-BEB1-C545D638F775Q26738682-560CC560-626D-4E6E-81D9-059E2CE76E01Q26799120-505E84F3-DFA9-415C-B113-D3B234F1E708Q26801808-B54B1D2B-44BA-464A-BAE4-8DDF2CA5F0DCQ27008342-61433FAA-36D2-40D3-B47F-713931B20891Q27012618-91627B94-A85D-4160-9A07-90BDE9F5DC4DQ27021570-E0C73092-00BD-4C29-9C16-3942087D1EBEQ27488697-69B3F445-9E9E-4A1B-A1BC-C1EF0C4CFF05Q28075712-5625513A-F9B9-434B-AFC2-2F60064F00A6Q28082828-FD456EBD-343F-4EBA-9034-601190D0ABCCQ28260997-72F5F605-0A77-4F70-A6E5-C40BC603A8A2Q28383942-0737B6E4-672C-4A95-9F56-E96A53A495FEQ30317628-7E2A554C-5DB5-4999-A84B-665074A03C3AQ33325670-5C8D0510-99C2-4125-8D44-A038975CCB16Q33488520-A2EE3E4A-9757-42DF-91E8-BA9E4DF3BB6CQ33506614-03C84F9F-15DB-4F63-9C90-51131EFB043EQ33712435-B9744623-64BA-4B0D-A9DD-8A7942F8AD84Q33889097-A5CC78FE-FCCC-440C-9257-16C00E19F3ADQ33993124-8BDFA23D-CBDB-4377-9C06-A5446F8BB7DEQ34055580-0438B320-A60F-44F8-BCA4-5176A0E19701Q34428428-842FBA4F-115F-4DDB-8412-025947B98803Q34476278-88FAFE29-C536-41D8-B8E0-41579B8AD108Q34557233-1EA275B1-CF30-42A6-8ACC-E1BCF70B0C5CQ34625147-FC05ABB6-53BC-4338-A290-009F0C661833Q34631825-CDD26710-A16B-49F7-BE7A-49F57846D8EAQ34635285-EE97146F-B7EF-483F-9BC9-301D80651611Q34657284-8358C4D7-13D3-4387-A61F-FFF2FD53C18DQ34661793-574DD779-C8F7-4FD7-8DBF-FFE54F3508EBQ34707334-744452A7-52EA-4781-BAE6-B8ADAA9BF3FCQ34755205-057D1E8C-AC4A-40B9-BF95-76E60EEBD956Q34880391-92681E73-54E6-4A79-9C7F-6234483B0CE7Q35012602-993D0159-BFCD-4472-8284-25A63A032AE2Q35093526-4BB9A6EE-A643-472F-9AD6-7FD0ECA48D9FQ35138135-7FC10454-9EEB-4F39-B9B6-A8E3E50EC3E7Q35606024-4BA773A0-2A29-4629-B537-069CD75894C7Q35699010-5A7F38D3-9E81-4DE6-B7CA-C0CA276BAA28Q35798822-1B19DD87-167A-4BA1-9AB7-3AB646FADE8FQ35882239-976033A0-8B5E-4BCA-BE24-8CA6FF74C0F8Q36120825-A5AC3BDA-2996-4DE4-A88B-AFBAC686D25EQ36200438-4AC068AB-5B00-4C7D-BF2B-485826E2145B
P2860
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
@ast
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
@en
type
label
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
@ast
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
@en
prefLabel
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
@ast
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
@en
P2093
P1433
P1476
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma
@en
P2093
Ben Daniel
Ilona Kryczek
Linhua Zou
Peter Mottram
Shuang Wei
Tyler Curiel
Weiping Zou
P304
P356
10.1158/0008-5472.CAN-04-4043
P407
P50
P577
2005-06-01T00:00:00Z